Ipilimumab vs Loratadine
Ipilimumab vs Loratadine: Overview
This comparison examines the pharmacological differences between Ipilimumab and Loratadine.
Mechanism of Action
Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.
Loratadine: Second-generation H1 antihistamine with minimal CNS effects.
Pharmacokinetics
Half-life: Ipilimumab β 14.7 days; Loratadine β 8 hours.
Chemical Properties
Molecular Formula: Loratadine β C22H23ClN2O2.
Molecular Weight: Loratadine β 382.8800 g/mol.
Type: Ipilimumab β Antibody; Loratadine β Small molecule.